Advocacy activity at EU level – 2012 onwards

One of PHA Europe’s missions is to ensure that EU-level policies and initiatives take better account of pulmonary hypertension and rare diseases as well as those affected by them. PHA Europe’s advocacy program aims to raise awareness of these issues with the three main EU institutions – The European Commission, Council of MInisters and European Parliament.

Last updated: August 25, 2015